At UroGen, making the impossible possible for patients with urological cancers is a reality, not just an idea.
Location: United States, New Jersey, Princeton
Employees: 51-200
Total raised: $75M
Founded date: 2004
Investors 4
| Date | Name | Website |
| 10.07.2026 | Aisling Ca... | aislingcap... |
| - | Two River ... | tworiver.c... |
| - | Arkin Hold... | arkinholdi... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2021 | - | $75M | - |
Mentions in press and media 17
| Date | Title | Description |
| 02.09.2026 | Reframe Systems Boosts Automated Home Construction with $40M Investment | Reframe Systems secured $40 million in new funding. This capital injection, led by Energy Impact Partners, will accelerate the company's mission. Reframe leverages robotics and software-driven microfactories. It aims to industrialize home c... |
| 01.09.2026 | Reframe Systems Raises $40M in Additional Funding | Reframe Systems, a Boston, MA-based physical AI company industrializing home construction, raised $40M in additional funding. The round was led by Energy Impact Partners (EIP), with participation from Counterpart Ventures, E12 Ventures, Glo... |
| 01.09.2026 | TrustedRouter Raises $1.25M in Seed Funding | TrustedRouter, a Miami, Florida-based artificial intelligence infrastructure and API orchestration startup, raised $1.25m in seed funding. Backers included Slow Ventures, Bill Tai, Linda Avey, and George Xing. The company will use the capit... |
| 12.01.2026 | Arkin Capital Closes $100 Million Bio Ventures III Fund For Early-Stage Biotech Investing | Arkin Capital announced it has closed Arkin Bio Ventures III, a $100 million fund that will back advanced pre-clinical and early clinical-stage biotechnology companies developing therapies for high unmet medical needs. The firm said the new... |
| 12.01.2026 | Arkin Capital Closes $100M Arkin Bio Ventures III to Back Advanced Pre-Clinical to Early Clinical-Stage Biotech Companies | What You Should Know: – Arkin Capital, a leading multi-asset investment manager, today announced the closing of Arkin Bio Ventures III, a $100 million fund focused on investing in advanced pre-clinical and early clinical-stage biotech compa... |
| 18.03.2021 | UroGen Pharma Announces $75 Million of Non-Dilutive Funding from RTW Investments | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 18, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced th... |
| 18.03.2021 | UroGen Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 18, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced fi... |
| 15.03.2021 | UroGen Pharma Announces Sponsored Research Agreement with the Johns Hopkins University School of Medicine to Expand Immuno-Oncology Pipeline | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 15, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced a ... |
| 11.03.2021 | UroGen Pharma to Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, March 18, 2021 | PRINCETON, N.J.--(BUSINESS WIRE)--Mar 11, 2021-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced th... |
| 05.05.2017 | Term Sheet — Friday, May 5 | CRYPTO-SPLAINING Last week a very confusing press release crossed my radar. It read: “The Argon Group is working on the first secondary market raise by ICO. The company, Storj had one of the most successful ICOs several years ago, returning... |
Show more